Dennis L. Ross

Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial

Katherine R. Tuttle, Sibylle J. Hauske, María Eugênia Fernandes Canziani et al. · The Lancet · 2023 · 151 citations · Full text

Hypertension, Renal Function, Renal Disease +10

Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trial

Jane E. Onken, David B. Bregman, Robert A. Harrington et al. · Nephrology Dialysis Transplantation · 2013 · 124 citations

Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial

Hiddo J.L. Heerspink, C. David Sjöström, Niels Jongs et al. · European Heart Journal · 2021 · 118 citations · Full text

Desferrioxamine therapy in hemodialysis patients with aluminum-associated bone disease

Arnold J. Felsenfeld, Mariano Rodríguez, Michael D. Coleman et al. · Kidney International · 1989 · 49 citations

Bone Disease, Hemodialysis, Chronic Kidney Disease +6

Efficacy of Exercise for End-Stage Renal Disease Patients Immediately following High-Efficiency Hemodialysis: A Pilot Study

Dennis L. Ross, Guy M. Grabeau, Sue Smith et al. · American Journal of Nephrology · 1989 · 26 citations

Physical Activity, Dialysis Therapy, Pilot Study +25